A systems Biology-Based classifier for hepatocellular carcinoma diagnosis

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Zhang, Yanqiong ^a,b   Wang, Shaochuang ^c   Li, Dong ^b   Zhnag, Jiyang ^d   Gu, Dianhua ^c   Zhu, Yunping ^b   He, Fuchu ^a,b  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d NATIONAL UNIVERSITY OF DEFENSE TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; NUCLEAR RECEPTOR COACTIVATOR 2; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC REGULATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PREDICTIVE VALUE; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SYSTEMS BIOLOGY; CANCER STAGING; CLASSIFICATION; DISEASE COURSE; DNA MICROARRAY; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PROTEIN PROTEIN INTERACTION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN INTERACTION MAPS; SYSTEMS BIOLOGY; TUMOR MARKERS, BIOLOGICAL;

EID: 79960872328     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022426     Document Type: Article

References (38)

1. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, et al. (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359: 1995-2004.
2. Sherman M, (2008) Recurrence of hepatocellular carcinoma. N Engl J Med 359: 2045-2047.
3. Sakamoto M, Mori T, Masugi Y, Effendi K, Rie I, et al. (2008) Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma. Intervirology Suppl 1 pp. 42-45.
4. Ikoma J, Kaito M, Ishihara T, Nakagawa N, Kamei A, et al. (2002) Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study. Hepatogastroenterology 49: 235-238.
5. Song PM, Zhang Y, He YF, Bao HM, Luo JH, et al. (2008) Bioinformatics analysis of metastasis-related proteins in hepatocellular carcinoma. World J Gastroenterol 14: 5816-5822.
6. Li Y, Tang Y, Ye L, Liu B, Liu K, et al. (2003) Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol 129: 43-51.
7. Goeman JJ, Buhlmann P, (2007) Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics 23: 980-987.
8. Dinu I, Potter JD, Mueller T, Liu Q, Adewale AJ, et al. (2007) Improving gene set analysis of microarray data by SAM-GS. BMC bioinformatics 8: 242.
9. Chen J, Yuan B, (2006) Detecting functional modules in the yeast protein-protein interaction network. Bioinformatics 22: 2283-2290.
10. Lu X, Jain V, Finn P, Perkins D, (2007) Hubs in biological interaction networks exhibit low changes in expression in experimental asthma. Molecular Systems Biology 3: 98.
11. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, et al. (2007) Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9: 166-180.
12. Gene Expression Omnibus (GEO) Available: http://www.ncbi.nlm.nih.gov/geo/. Accessed 2011 Jul 12.
13. Stanford MicroArray Database (SMD) Available: http://genome-www5.stanford.edu/. Accessed 2011 Jul 12.
14. Storey JD, Tibshirani R, (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100: 9440-9445.
15. Chen X, Cheung ST, So S, Fan ST, Barry C, et al. (2002) Gene expression patterns in human liver cancers. Mol Biol Cell 13: 1929-1939.
16. Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, et al. (2007) Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45: 938-947.
17. Baldi P, Brunak S, Chauvin Y, Andersen CA, Nielsen H, (2000) Assessing the accuracy of prediction algorithms for classification: an overview. Bioinformatics 16: 412-424.
18. Chadha KS, Khoury T, Yu J, Black JD, Gibbs JF, et al. (2006) Activated Akt and Erk Expression and Survival After Surgery in Pancreatic Carcinoma. Annals of Surgical Oncology 13: 933-939.
19. Ludbrook J, (2008) Analysis of 2×2 tables of frequencies: matching test to experimental design. Int J Epidemiol 37: 1430-1435.
20. Jeong H, Mason SP, Barabási AL, Oltvai ZN, (2001) Lethality and centrality in protein networks. Nature 411: 41-42.
21. Liu P, Ramachandran S, Ali Seyed M, Scharer CD, Laycock N, et al. (2006) Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res 66: 4011-4019.
22. Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, et al. (2005) Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8: 393-406.
23. Rioux PA, Gilbert WA, Littlejohn TG, (1994) A portable search engine and browser for the Entrez database. J Comput Biol 1: 293-295.
24. Normanno N, Maiello MR, De Luca A, (2003) Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action? J Cell Physiol 194: 13-19.
25. Kannangai R, Sahin F, Torbenson MS, (2006) EGFR is phosphorylated at Ty845 in hepatocellular carcinoma. Modern Pathology 19: 1456-1461.
26. Giannelli G, Azzariti A, Sgarra C, Porcelli L, Antonaci S, et al. (2006) ZD6474 inhibits proliferation and invasion of human hepatocellular carcinoma cells. Biochem Pharmacol 71: 479-485.
27. Höpfner M, Sutter AP, Huether A, Schuppan D, Zeitz M, et al. (2004) Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma. J Hepatol 41: 1008-1016.
28. Huether A, Höpfner M, Baradari V, Schuppan D, Scherübl H, (2005) EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer. Biochem Pharmacol 70: 1568-1578.
29. van Nimwegen MJ, van de Water B, (2007) Focal adhesion kinase: A potential target in cancer therapy. Biochem Pharmacol 73: 597-609.
30. Braren R, Hu H, Kim YH, Beggs HE, Reichardt LF, et al. (2006) Endothelial FAK is essential for vascular network stability, cell survival and lamellipodial formation. J Cell Biol 172: 151-162.
31. Peng X, Ueda H, Zhou H, Stokol T, Shen T-L, et al. (2004) Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice. Cardiovascular Res 64: 421-430.
32. Bagi C, Christensen J, Cohen D, Roberts W, Wilkie D, et al. (2009) Sunitinib and PF-562,271 (FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model. Cancer Biology & Therapy 8: 9, 856-865.
33. Scherf U, Ross DT, Waltham M, (2000) A gene expression database for the molecular pharmacology of cancer. Nature Genet 24: 236-244.
34. Furey TS, Cristianini M, Duffy N, Bednarski DW, Schummer M, et al. (2000) Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 16: 906-914.
35. Segal E, Friedman N, Kaminski N, Regev A, Koller D, (2005) From signatures to models: understanding cancer using microarrays. Nature Genet 37: S38-S45.
36. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437: 1032-1037.
37. Liu CC, Chen WE, Lin CC, Liu HC, Chen HY, et al. (2006) Topology-based cancer classification and related pathway mining using microarray data. Nucleic Acids Research 34: 4069-4080.
38. Eschrich S, Zhang HL, Zhao HY, Boulware D, Lee JH, et al. (2009) Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. Int J Radiation Oncology Biol Phys 75: 497-505.